Funding · Company
Paragon Biosciences Emalex Capital, Inc.
Chicaco, ILBiotech & Pharma
Paragon Biosciences Emalex Capital, Inc. of Chicaco, IL has disclosed $295M across 2 Form D offerings filed with the SEC between Nov 4, 2022 and Jul 8, 2025.
$295M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$270M
Form D · Jul 8, 2025 ↗
Q3 2025
· 3 amendments, first filed Nov 4, 2022
Filing details
HeadquartersChicaco, ILIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2018SEC CIK0001749990Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →